1. Home
  2. NKSH vs NTHI Comparison

NKSH vs NTHI Comparison

Compare NKSH & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKSH
  • NTHI
  • Stock Information
  • Founded
  • NKSH 1891
  • NTHI 2008
  • Country
  • NKSH United States
  • NTHI United States
  • Employees
  • NKSH N/A
  • NTHI N/A
  • Industry
  • NKSH Major Banks
  • NTHI Biotechnology: Pharmaceutical Preparations
  • Sector
  • NKSH Finance
  • NTHI Health Care
  • Exchange
  • NKSH Nasdaq
  • NTHI Nasdaq
  • Market Cap
  • NKSH 199.9M
  • NTHI 229.0M
  • IPO Year
  • NKSH N/A
  • NTHI N/A
  • Fundamental
  • Price
  • NKSH $29.20
  • NTHI $12.09
  • Analyst Decision
  • NKSH Strong Buy
  • NTHI
  • Analyst Count
  • NKSH 1
  • NTHI 0
  • Target Price
  • NKSH $38.00
  • NTHI N/A
  • AVG Volume (30 Days)
  • NKSH 8.0K
  • NTHI 129.9K
  • Earning Date
  • NKSH 10-23-2025
  • NTHI 11-19-2025
  • Dividend Yield
  • NKSH 5.21%
  • NTHI N/A
  • EPS Growth
  • NKSH 15.57
  • NTHI N/A
  • EPS
  • NKSH 1.77
  • NTHI N/A
  • Revenue
  • NKSH $49,801,000.00
  • NTHI $59,990.00
  • Revenue This Year
  • NKSH $2.95
  • NTHI N/A
  • Revenue Next Year
  • NKSH $9.97
  • NTHI N/A
  • P/E Ratio
  • NKSH $16.35
  • NTHI N/A
  • Revenue Growth
  • NKSH 16.22
  • NTHI N/A
  • 52 Week Low
  • NKSH $23.75
  • NTHI $3.20
  • 52 Week High
  • NKSH $32.89
  • NTHI $25.00
  • Technical
  • Relative Strength Index (RSI)
  • NKSH N/A
  • NTHI N/A
  • Support Level
  • NKSH N/A
  • NTHI N/A
  • Resistance Level
  • NKSH N/A
  • NTHI N/A
  • Average True Range (ATR)
  • NKSH 0.00
  • NTHI 0.00
  • MACD
  • NKSH 0.00
  • NTHI 0.00
  • Stochastic Oscillator
  • NKSH 0.00
  • NTHI 0.00

About NKSH National Bankshares Inc.

National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

Share on Social Networks: